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Abstract 
The accumulation of cleaved tau fragments in the brain is associated with several tauopathies. For 
this reason, we recently developed a transgenic mouse that selectively accumulates a C-Terminal 35 
kDa human tau fragment, Tau35. These animals develop progressive motor and spatial memory 
impairment, paralleled by increased hippocampal glycogen synthase kinase 3β activity. In this 
neurophysiological study we focused on the CA1 subfield of the hippocampus, a brain area involved 
in memory encoding. The accumulation of Tau35 results in a significant increase of short-term 
facilitation of the synaptic response in the theta frequency range (10 Hz), without affecting basal 
synaptic transmission and long term-synaptic plasticity. Tau35 expression also alters the intrinsic 
excitability of CA1 pyramidal neurons. Thus, Tau35 presence is associated with increased and 
decreased excitability at hyperpolarized and depolarized potentials, respectively.  These 
observations are paralleled by a hyperpolarization of the voltage-sensitivity of non-inactivating K
+
 
currents. Further investigation is needed to assess the causal link between such functional 
alterations and the cognitive and motor impairments previously observed in this model. 
 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
3 
 
Introduction 
A range of neurodegenerative tauopathies in humans are characterized by the progressive 
accumulation of pathogenic tau aggregates within the central nervous system (CNS). These 
conditions are associated with diverse clinical outcomes, which may consist of both cognitive and 
motor impairments, as extensively reviewed (Goedert and Spillantini, 2011; Lee et al., 2001; 
Spillantini and Goedert, 2013). Alzheimer’s disease represents the most common form of tauopathy.  
Its pathological outcomes coexist with, and may be a consequence of, amyloidopathy (Hardy and 
Allsop, 1991; Hardy and Higgins, 1992). Neurodegenerative diseases that are purely associated with 
the progressive accumulation of tau protein species, include frontotemporal dementia (FTD), 
progressive supranuclear palsy (PSP) and cortico-basal degeneration (CBD). PSP is characterized 
histopathologically by neurodegeneration of midbrain and brainstem structures, including 
hypothalamus and basal ganglia (Pollock et al., 1986), and clinically by postural instability (Steele et 
al., 1964).  
 
In tauopathy, the tau protein can be subject to a range of disease-associated post-translational 
modifications, the most explored one being its phosphorylation. The altered phosphorylation of tau 
protein leads to the formation of neurofibrillary tangles and the occlusion of its ability to interact 
with microtubules; hyperphosphorylated tau is associated with all the above mentioned 
neurodegenerative conditions (Spillantini and Goedert, 2013).  Ubiquitination and tau truncation are 
also characteristic modifications observed in human tauopathies (Martin et al., 2011). 
 
The majority of tauopathies are sporadic, and some lines of evidence suggest that the accumulation 
of tau fragments plays a part in the pathogenesis of some or all of these conditions. For instance we 
previously identified an N-terminally truncated form of tau in human brain that is highly 
phosphorylated and associated with the development of 4-repeat forms of human tauopathy, such 
as PSP (Guo et al., 2017; Wray et al., 2008). This work on human disease tissues was followed-up by 
the production of a novel mouse model in which the brain-derived, C-terminal 35 kDa tau fragment 
(Tau35) was expressed under control of the human tau promoter (Bondulich et al., 2016). The 
expression of the construct was introduced into the mouse hypoxanthine phosphoribosyl 
transferase (Hprt) locus (Bronson et al., 1996), guaranteeing single copy targeted integration. This 
both eliminates potential gene disruption around the insertion site and avoids artefacts due to tau 
overexpression. Correspondingly, in this animal the Tau35 transgene was only expressed at a low 
level, accounting for less than 10% of the level of endogenous mouse tau. 
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Tau35 mice progressively develop a number of key aspects of human tauopathies. These include the 
appearance of aggregated and abnormally phosphorylated tau, increased glycogen synthase kinase 
3β (GSK3β) activity, deficits in cognitive and motor function, premature death, dysfunction 
associated with autophagy and lysosomal processing and a decline in synaptic protein levels. 
Cognitive decline was revealed in Tau35 mice by an age-dependent impairment in their performance 
in the Morris water maze, a well-validated hippocampal-dependent spatial memory task (Bondulich 
et al., 2016). 
 
This work examines the neurophysiological function of the Tau35 mouse in the CA1 subfield of the 
hippocampus, an area with a well-established role in spatial navigation and memory (Chersi and 
Burgess, 2015). The experiments were all performed on mice aged 14-18 months. This is an age 
beyond which water maze learning is eliminated and is the age point at which biochemical and 
immunohistochemical measurements revealed a number of key alterations to hippocampal 
neurochemistry. These include tangle-like structures reactive for a broad range of tau antibodies, 
changes to tau phosphorylation, increased GSK-3β activity, altered levels of synaptic proteins and 
modifications indicative of altered autophagic processing. Our experiments reveal that, as seen in 
other models of tauopathy (Booth et al., 2016b), long-term synaptic plasticity is unaltered in the 
Schaffer collateral commissural pathway (SCCP). However we did observe genotype-associated 
changes to short-term synaptic plasticity and intrinsic excitability properties of CA1 pyramidal 
neurons that may contribute to the loss of spatial memory these mice exhibit.   
 
Materials and methods. 
 
Experimental animals 
In all experiments, animals expressing the Tau35 transgene were compared against age matched 
wild-type littermate controls (36 animals; 17 WT, 19 TG). Figure 1 shows a schematic representation 
of the Tau35 fragment compared to human tau; this is the product of the expression of the Tau35 
genetic construct described in our previous work (Bondulich et al., 2016). Animals were bred at 
King’s College London and arrived in a single shipment to the University of Exeter Medical School 
prior to the commencement of the study. They were group housed, allowed food and water ad 
libitum and maintained on a 12:12 hour light/dark cycle. This study was carried out in accordance 
with UK Home Office Guidelines and the King’s College London and University of Exeter Animal 
Welfare Ethical Review Board.  
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Preparation of brain slices.  
Animals were sacrificed using cervical dislocation in accordance with Schedule 1 of the Animals 
(Scientific Procedures) Act (1986). The brain was rapidly removed and transferred to an ice cold 
cutting solution consisting of (in mM): 189 Sucrose, 10 D-Glucose, 26 NaHCO3, 3 KCl, 5 MgSO4(7H2O), 
0.1 CaCl2, 1.25 NaH2PO4. 300 µm coronal sections were cut using a Leica VT1200 microtome and 
immediately transferred to a holding chamber containing artificial cerebrospinal fluid (aCSF) 
continuously bubbled with carbogen. The composition of the aCSF was as follows (in mM): 124 NaCl, 
3 KCl, 24 NaHCO3, 2 CaCl2, 1.25 NaH2PO4, 1 MgSO4, 10 D-glucose. The slices were then allowed to 
recover for 30 min at 37° C and subsequently at room temperature for at least 1 hour prior to 
transfer into a recording chamber. Field potential and whole-cell recording experiments were carried 
out on different brain slices. 
 
Whole cell patch clamp recordings 
Slices were transferred to a recording chamber where they were submerged in carbogen-
equilibrated aCSF and maintained at a temperature between 33-34 ° C. The recording chamber was 
secured on the stage of an Olympus BX51 upright microscope and individual CA1 pyramidal neurons 
were visualised using infrared differential interference contrast optics. Borosilicate glass 
microelectrodes with a resistance ranging from 3-5 MΩ were pulled, fire-polished and filled with a K-
Gluconate based internal solution consisting of (in mM): 135 K-gluconate, 5 NaCl, 10 HEPES free acid, 
0.2 EGTA, 0.3 Na-GTP, 4 Mg-ATP, 13.4 Biocytin (pH 7.3, 280-290 mOsm). Following entry into whole 
cell configuration, a junction potential error of 15 mV arose due to the pairing of the pipette solution 
with the aCSF, which was arithmetically corrected for during analysis. Signals were recorded using a 
Multiclamp 700B amplifier, digitised using a Digidata 1440 and stored for future analysis using 
pClamp 10 software. 
 
All recordings were made from a defined pre-stimulus membrane potential set by injecting a 
continuous flow of bias current through the recording electrode. This facilitated the analysis of 
passive neuronal properties and action potential (AP) generation from pre-stimulus membrane 
potentials (Vm) of both -80 and -74 mV. In order to measure neuronal passive membrane properties 
a 500 ms, -100 pA hyperpolarising current step was injected across the membrane from each Vm. 
The subsequent voltage deflection at the steady state of the hyperpolarisation was used to calculate 
the input resistance (Rin) of the membrane using Ohm’s law (V = IR). The extrapolation of a single 
exponential curve at an infinite time, fitted to the membrane charging response between 10 and 
95% of the peak amplitude, was used to calculate the membrane time constant (τ). An 
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approximation of capacitance was measured as the ratio between the τ and Rin. Sag, measured as 
the difference between the negative peak and the steady state hyperpolarisation, was expressed as 
a percentage of the peak hyperpolarisation in response to a 500 ms, -100 pA hyperpolarising current 
injection.   
 
Standard “Zap” protocols were used to measure subthreshold membrane resonance properties, as 
previously described (Hu et al., 2002; Tamagnini et al., 2014). Briefly, the ratio of the Fast-Fourier 
transform of the voltage response versus the current injection was calculated as a measure of the 
impedance profile of the pyramidal neurons (Z = Vfft/Ifft). Subsequently the impedance versus 
frequency profile was smoothed with a 35 point moving average function (sZ). Cell-to-cell maximal 
impedance (Z max, MΩ), frequency at which this maximal impedance occurred (Peak frequency, Hz), 
quality factor of the resonator (Q) and area under the curve (AUC, sZ*Fr) were quantified to 
facilitate comparisons between the genotypes.  
 
In order to quantify neuronal excitability, a series of incremental 500 ms depolarising square current 
injections, ranging from 50 – 300 pA, were injected across the membrane. The number of AP 
generated for each current injection was used as a measure of excitability. The pattern of neuronal 
firing was also examined by plotting the instantaneous frequency between APs versus the interval 
number. The first AP fired in response to a 300 pA depolarising current step was used to compare AP 
waveforms between the genotypes. AP threshold was quantified, defined as the voltage at which 
the rate of rise (dV/dt) surpassed 20 V*s
-1
. AP width was measured at -15 mV while the AP rate of 
rise (RoR) was measured for each cell as the RoR of the membrane potential at -20 mV during the 
rising phase of the AP. 
 
Short-term plasticity was measured by evoking a train of 6 excitatory post-synaptic potentials 
(EPSPs) at 1 Hz, 3 Hz, 10 Hz, and 30 Hz. Each individual EPSP was elicited by delivering a 0.1 ms 
current pulse through a tungsten bipolar stimulating electrode placed on axons of the Schaffer 
collateral pathway. Stimulus intensity was set to produce measurable EPSPs without reaching 
threshold for triggering an AP. To analyse the relative increase in EPSP amplitude during the pulse 
train each value was normalised to the amplitude of the EPSP evoked by the first stimulus in the 
train and area under curve was calculated for each cell: for each stimulation frequency, data were 
compared between genotypes.  
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For voltage-clamp experiments, outside-out, somatic, nucleated macropatches were excised as 
previously described (Brown et al., 2011). Pipette capacitance was neutralized and the series 
resistance was compensated for (10% – 80% correction). VC recordings were made for the 
quantitative evaluation of outward-going plateau voltage-gated K
+
 currents, by applying 30 ms 
voltage steps, growing in 10 mV increments and starting from a holding voltage of -90 mV. Each 
recorded current amplitude was normalized to the membrane capacitance of the macropatch in 
order to account for differences in current amplitude arising from different sizes of the macropatch. 
The specific current (pA/pF) was used to calculate the specific conductance to K
+
 ions based on a 
Nernstian equilibrium potential of -100 mV.   
 
Field Excitatory postsynaptic potentials 
Following the initial post-slicing recovery period, the CA3 region of hippocampal slices was removed 
using a scalpel cut. Slices were then transferred to a recording chamber in which they were 
submerged in continually perfused aCSF pre-equilibrated with carbogen and maintained at a 
temperature between 32 - 33 ° C. Field excitatory postsynaptic potentials (fEPSPs) were elicited by 
delivering a short pulse of electrical current (0.1 ms) through tungsten bipolar stimulating 
electrodes. These stimulating electrodes were placed such as to stimulate axons of the Schaffer 
Collateral (SC) or temporoammonic (TA) pathways. Borosilicate glass recording microelectrodes with 
a resistance ranging from 3-5 MΩ were pulled and filled with aCSF. Recorded signals were collected 
with an Axoclamp 2B amplifier, digitised with a Digidata 1322A and stored for future analysis using 
pClamp 10 software.  
 
 For the majority of input output curves and long-term potentiation (LTP) experiments the SC and TA 
pathways were stimulated alternatively every 15 s, however in some cases experiments focused on 
an individual pathway. Input-output curves were constructed by incrementally increasing the 
current passing through the stimulating electrode and recording the evoked response (25 - 300 µA in 
25 µA steps for the SC pathway, 125 – 1500 µA in 125 µA steps for the TA pathway). Following this, 
the threshold stimulation intensity required to elicit a visually detectable fEPSP was found. The 
stimulus intensity was then set at 3 times the threshold level for the remainder of the recording.  
 
After a period of at least 20 minutes recording baseline responses at low frequency, induction of LTP 
was attempted in one pathway using a theta burst stimulation (TBS) protocol. This consisted of 5 
bursts of 10 stimuli at 100 Hz applied with an interburst interval of 200 ms. This was repeated 4 
times with an inter-repeat interval of 20s.  The fEPSPs were then followed for 1 hour before the TBS 
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protocol was delivered to the other pathway and fEPSPs were followed for another hour. The order 
in which the pathways were stimulated was alternated between experiments.  
 
Data analysis 
Data were analysed using a range of custom written MATLAB scripts, pClamp and Origin 9.1 analysis 
tools. The approaches used for the analysis of intrinsic properties are described in (Tamagnini et al., 
2014). Statistical assessments of differences between genotypes were made using unpaired two-
tailed Student’s t-tests (with or without Bonferroni correction -bc- for multiple comparisons) and 
two-way analysis of variance (ANOVA) as appropriate; non-parametric Mann-Whitney U test was 
used for normalized data. Figures were prepared with Origin 9.1. Data are shown as mean ± SEM 
values. 
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Results 
High levels of 35 kDa cleaved tau protein (Tau35) have been found in the brain of patients affected 
by PSP (Wray et al., 2008). By performing electrophysiological recordings in the CA1 subfield of the 
dorsal hippocampus of 14-18 month old Tau35 mice and age-matched littermate controls, our study 
aimed to characterize the functional neurophysiological consequences of chronic exposure to C-
terminal 35 kDa fragments of tau protein. First, we used extracellular field potential recordings to 
examine synaptic transmission and long-term plasticity at excitatory synapses in the CA1 subfield of 
the hippocampus. Historically, this has unquestionably been the most commonly made assessment 
of neurophysiological function in rodent models of human dementia (Randall et al., 2010). To 
parallel other recent studies in our laboratory (Booth et al., 2014; Booth et al., 2016b) we looked at 
both Schaffer collateral (SC)-CA1 and Temporo-ammonic (TA) synaptic function. 
Contemporaneously, but on separate slices, we employed whole-cell patch clamp recordings from 
single CA1 pyramidal cells to assess both short-term synaptic plasticity on SC-CA1 synapses and the 
intrinsic excitability membrane properties of CA1 excitatory pyramidal neurons.  
 
Extracellular recordings of evoked field EPSPs, revealed no difference in basal synaptic transmission 
in either pathway (data not shown; CA1-SC - Two-way repeated measures (RM) ANOVA, source of 
variability=genotype, F=0.95, P=0.35; TA-CA1 – Two-way RM ANOVA, source of variability=genotype, 
F=1.45, P=0.26). We also observed no difference in the ability to induce LTP in either SC-CA1 or TA-
CA1 synapses (Figure 2; SC-CA1 - Mann-Whitney U Test, source of variability = genotype; P=0.4; TA-
CA1 – Mann-Whitney U Test, source of variability = genotype, P=0.46) in Tau35 mice when 
compared with their WT littermate controls.  
 
In addition, whole-cell patch-clamp recordings of EPSPs in CA1-PCs, evoked by the repeated 
stimulation of SC fibres (6 pulses delivered at 1 Hz, 3 Hz, 10 Hz and 30 Hz), revealed an increase in 
short-term synaptic plasticity in Tau35 mice. This was apparent at a stimulus frequency of 10 Hz, a 
frequency within the theta band range, but not at the three other stimulation frequencies tested, 
(Figure 3; Mann-Whitney U Test, source of variability = genotype; 1 Hz, P=0.829; 3 Hz P=0.193; 10 Hz 
P=0.018; 30 Hz P=1).  
 
We, and others, have described differences in intrinsic excitability membrane properties of 
hippocampal neurons in a number of murine models of human dementia (Brown et al., 2011; 
Kerrigan et al., 2014; Siskova et al., 2014; Tamagnini et al., 2015a; Tamagnini et al., 2015b; Wykes et 
al., 2012) including models of FTD (Booth et al., 2016b). Consequently, we compared intrinsic 
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excitability properties of Tau35 and WT control mice using whole cell current-clamp recordings from 
CA1-PCs. No differences were observed in the resting membrane potential (RMP) (Figure 4; Tau35, 
RMP=-76.6 mV ± 1.3 mV n=47; WT, RMP=-74.1 mV ± 1.6 mV n=32, unpaired Student’s t-test P=0.2). 
In order to avoid biases arising from cell-to-cell variability in RMP, all the other intrinsic excitability 
properties were measured from two fixed pre-stimulus Vm, -80 mV and -74 mV respectively. These 
pre-stimulus levels were established with a suitable level of bias current injection. We chose to 
record the intrinsic excitability properties from the two different pre-stimulus potentials as we 
wanted to gather information on the intrinsic excitability properties arising from a potential that was 
(1) close to the average value RMP (i.e. -74 mV), and (2) sufficiently hyperpolarized to measure sub-
threshold oscillatory properties of the cell (i.e. -80 mV).  
 
The hyperpolarization response resulting from the injection of a -100 pA, 500 ms square current 
step, allowed us to measure membrane passive properties, such as Rin, τ and capacitance of the 
membrane. This response also allowed us to measure the Ih-dependent “sag” we have found to be 
altered in rTg4510 mice, a transgenic model of progressive tauopathy (Booth et al., 2016b). Two-way 
RM ANOVA showed an overall effect of genotype (between subjects) and Voltage (within subjects) 
but no interaction between genotype and voltage for Rin (Genotype: F=6.06, P=0.016; Voltage: 
F=177.05, P<0.0001; Genotype*Voltage: F=0.933, P=0.34). Unpaired Student’s t-test with Bonferroni 
correction for multiple comparisons, revealed that Rin was not significantly different between 
genotypes when the pre-stimulus Vm was held at -80 mV (Figure 5A, see bottom panels), but it was 
significantly lower in Tau35 mice when the pre-stimulus Vm was -74 mV (Figure 5B, see bottom 
panels). In addition, capacitance was significantly higher in Tau35 mice at both tested pre-stimulus 
Vm (Figure 5, bottom panels) but no effect of voltage nor interaction between genotype and voltage 
was observed (Voltage: F=0, P=0.99; Genotype*Voltage: F=0.510, P=0.478). No differences were 
observed in other passive properties examined, such as sag and τ. The lack of change in τ reflects the 
balancing of the ~20% increase in capacitance by a reciprocal decrease in Rin (although this was not 
statistically significant at -80 mV). See Table 1 for mean ± SEM, F and P values.  
 
If an oscillating current of linearly increasing frequency and of sub-threshold intensity is injected, the 
oscillatory impedance properties of the cell can be explored. Our data showed that the cell 
impedance (Z) was lower across the whole frequency spectrum, as revealed by cell-to-cell analysis of 
the area under curve (AUC) in frequency vs impedance (Figure 5C, right panel; Tau35,  AUC=1725 
Hz*MΩ ± 103 Hz*MΩ n=49; WT, AUC=2191 Hz*MΩ ± 153 Hz*MΩ n=30, Unpaired Student’s t-test 
P=0.01). This finding is in line with the lower Rin in this group (Figure 5 and Table 1). However, no 
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significant changes were observed in cell-to-cell analysis of peak Z, peak frequency and the quality 
factor of the resonator (Q), as summarized in Table 2 (showing mean ± SEM and P values). 
 
Supra-threshold firing properties were explored using 500 ms duration step injections of 
depolarizing current. These ranged in amplitude from -50 pA to 300 pA in 50 pA increments. As for 
the determination of passive properties, these were applied from a pre-stimulus membrane 
potential of both -80 mV and -74 mV. With a pre-stimulus potential of -80 mV no significant 
differences between genotypes were observed in the total spike output (Figure 6A, top panel; Two-
way RM ANOVA, source of variability = genotype, F=1.121, Pbc=0.586) or dynamics of spiking firing. 
The latter is illustrated for a 300 pA stimulus by the bottom panel of (Figure 6A, bottom panel; Two-
way RM ANOVA, source of variability = genotype, F=0.820, Pbc=0.736). In contrast, when measured 
from a pre-stimulus membrane potential of -74 mV, the total spike output was significantly lower in 
Tau35 mice compared to age-matched WT controls (Figure 6B, top panel; Two-way RM ANOVA, 
source of variability = genotype, F=9.170, Pbc=0.006). This was also reflected in the temporal 
dynamics of firing as illustrated for a 300 pA stimulus in the bottom panel of (Figure 6B Two-way RM 
ANOVA, source of variability = genotype, F=6.085, Pbc=0.032). These results show a reduction of 
excitability of hippocampal CA1-PCs in Tau35 mice, at slightly more depolarized RMPs.  
 
As well as characterizing the extent and dynamics of depolarization-induced AP firing, we also 
investigated the genotype-dependence of AP waveform as we (Brown et al., 2011; Kerrigan et al., 
2014; Tamagnini et al., 2015a; Tamagnini et al., 2015b) and others (Wykes et al., 2012) have seen 
this change in other rodents exhibiting dementia-associated pathology. In this regard, we observed 
an overall effect (Two-way RM ANOVA) of genotype on the AP threshold, but no effect of voltage 
nor interaction between genotype and voltage (Genotype: F=4.923, P=0.031; Voltage: F=0.004, 
P=0.948; Genotype*Voltage: F=1.816, P=0.183). Multiple comparisons between genotypes at each 
voltage revealed a 3 mV hyperpolarization of the AP threshold in Tau35 mice vs age-matched WT 
littermate controls for recordings made from a pre-stimulus holding Vm=-80 mV (Figure 7C; unpaired 
t-test with Bonferroni correction for multiple comparisons, Pbc=0.006). Although the AP threshold 
was 1.5 mV more hyperpolarized in Tau35 mice when current stimuli were delivered to cells at -74 
mV, this was not a significant difference (Figure 7D; unpaired t-test with Bonferroni correction for 
multiple comparisons, P=0.17). In addition, the rate of rise of the AP measured in each cell at -20 mV 
was significantly faster in Tau35 mice and slower (as an overall effect of voltage across genotypes) at 
more depolarized potentials (Figure 7E-F; Two-way RM ANOVA for Genotype: F=5.661, P=0.021; 
Voltage: F=4.197, P= 0.045; Genotype*Voltage: F=0.124, P=0.726). Unpaired Student’s t-tests 
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between genotypes with Bonferroni correction for multiple comparisons at both pre-stimulus 
potentials tested, revealed that the AP rate of rise was higher at both tested potentials (Pbc=0.048 at 
-80 mV and P=0.03 at -74 mV, respectively). AP width and AP peak were not significantly different 
between genotypes. For a summary of AP waveform properties see Table 3. This observation allows 
us to conclude that CA1-PCs from Tau35 are hyperexcitable and this effect might be more 
pronounced at more polarized potentials. Series resistance (Rs) was compensated for in each 
recording; Rs was not different between genotypes (WT Rs=13.5 ± 0.3; Tau35  Rs=13.5 ± 0.4, 
Unpaired Student’s t-test P=0.97). 
 
 
The changes to intrinsic excitability properties outlined above likely have a significant component of 
their basis in the underlying ion channel complement of CA1 pyramidal cells (CA1-PCs). In the past 
we have studied changes of this nature in dementia models using voltage clamp methods to 
characterize voltage-gated current components (Brown et al., 2011). Notably, due to the complex 
geometry and size of pyramidal neurones, and the large currents they express, using conventional 
whole cell methods for such recordings can have limited utility. To circumvent these issues, we 
employed, as in our previous work (Brown et al., 2011), nucleated somatic macropatches to examine 
voltage-gated channels. An example of an outside-out, somatic macropatch excised from a CA1 cell 
in this study is shown in the top panel of Figure 8A; example voltage-gated outward K
+
 currents are 
shown below (Figure 8B).  Pooled data plotting the activated K
+
 conductance versus voltage 
relationships from 9 WT and 10 Tau35 macropatches are shown in Figure 8B.  No effect of genotype 
was observed on Gmax (Figure 8C; WT n=9, Gmax= 2.2 ± 0.7 nS/pF vs Tau35 n=10, Gmax= 1.3 ± 0.4 nS/pF; 
P=0.2), possibly due to the considerable cell-to-cell variability in the populations of macropatches 
from both genotypes. We did observe, however, a striking and significant shift in the voltage-
dependence of K
+
 current activation, which is better illustrated by the peak-normalized 
conductance-voltage plots shown in Figure 8D. These highlight the 8 mV more negative activation 
curve seen in Tau35 mice (Figure 8C; WT n=9,  V1/2= -14.81 ± 2.05 mV vs Tau35 n=11,  V1/2= -23.15 ± 
1.87 mV; P=0.007). The Boltzmann slope factor of the current activation was not affected by 
genotype. These results underlie and parallel the reduction of excitability observed in Tau35 mice at 
more depolarized potentials.  
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Discussion 
Tauopathies are neurodegenerative disorders characterized by the progressive accumulation of 
neurotoxic hyperphosphorylated tau species within the CNS. Tauopathy is the major hallmark of 
several neurodegenerative diseases that are predominantly characterized by cognitive decline and 
dementia, for example Alzheimer’s disease and Pick’s disease. Tauopathy is also a cardinal feature of 
certain diseases where cognitive decline is accompanied by progressive development of motor 
deficits, such as PSP and CBD (Goedert and Spillantini, 2011; Iqbal et al., 2016; Lee et al., 2001; Lopez 
Gonzalez et al., 2016; Spillantini and Goedert, 2013; Wray et al., 2008). Even if some tauopathies are 
genetic disorders, most of them are sporadic events, depending on both genetic (Mitsui and Tsuji, 
2014) and environmental risk factors. It has been shown, for instance, that a highly phosphorylated 
35 KDa fragment of tau protein in human brain is associated with tauopathies, such as PSP (Wray et 
al., 2008). Tau35 transgenic mice were developed to model the accumulation of the 35 KDa C-term 
fragment of human tau and the first characterization of these mice was recently published. It 
described neurological symptoms relating to both progressive motor and cognitive decline 
paralleling the progressive tauopathy. In addition, it showed the progressive accumulation of 
hyperphosphorylated pathogenic tau forms associated to the Tau35 genotype, paralleled by GSK-3β 
accumulation and autophagy impairment (Bondulich et al., 2016). In this respect, Tau35 mice can 
perhaps be regarded as a first model, expressing wild-type tau, of sporadic tauopathies such as PSP, 
FTD and CBD. 
 
In this study, we have made a first neurophysiological characterization of Tau35 mice. We chose to 
examine the CA1 area of the dorsal hippocampus as this has been widely studied in many dementia 
models and it is pertinent to the spatial memory deficit reported in these animals using the Morris 
water maze (Bondulich et al., 2016). We examined aspects of both                                                      
synaptic function and  single cell intrinsic excitability properties in a single study cohort of 14-18 
month old Tau35 and age-matched WT littermate controls. 
  
Extracellular field recordings of EPSPs indicated that brain slices prepared from Tau35 mice exhibited 
normal theta-burst induced LTP in Schaffer collateral/CA1 synapses. LTP was also intact when 
synaptic inputs to the deep dendrites of CA1 cells such as the temporo-ammonic pathway were 
stimulated (Figure 2). Although these outcomes may be surprising for some, LTP in various 
hippocampal pathways has been reported to be intact in many transgenic models of human 
dementia pathology, including both models of amyloidopathy (Brown et al., 2005; Fitzjohn et al., 
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2001; Hsia et al., 1999) and tauopathy (Booth et al., 2016b; Maeda et al., 2016; Randall et al., 2010; 
Scott et al., 2016). 
 
When the short-term facilitation of Schaffer-collateral EPSPs was tested with whole-cell current-
clamp recordings of stimulus train-evoked EPSPs in CA1-PCs, a difference in short-term synaptic 
plasticity was seen. When EPSPs were driven with short 1 Hz trains, the responses from the 2 
genotypes were almost identical with a 20% response facilitation developing over the 6 pulse train.  
With 3 Hz trains, Tau35 responses appeared to grow more, but this did not quite reach a significant 
level; however, a similar and statistically significant outcome was seen with 10 Hz synaptic 
activation. Thus, in Tau35 mice, EPSPs both initially grew more and maintained their increase 
throughout the train. This meant the overall depolarizing envelope of the EPSP was some 55% larger. 
Interestingly, the frequency at which EPSP facilitation is most striking, lies in the theta frequency 
range, paralleling the most prominent in vivo hippocampal network oscillation in awake behaving 
rodents, and one that is also impaired in other models of tauopathy (Booth et al., 2016b).   
 
It is interesting to consider the potential underlying mechanism for the enhanced short-term 
plasticity at Schaffer collateral synapses in Tau35 mice. This could reflect a lower basal probability of 
release and, although extracellular recordings of input-output curves did not suggest this, these 
could be affected by other factors including an enhanced axonal excitability. This hypothesis is in line 
with the decrease in synapsin-1 we previously observed in Tau35 (Bondulich et al., 2016) where we 
speculated that such decrease might result in a selective loss of releasable vesicles but not 
synaptophysin-regulated endocytosis of synaptic vesicles. This result parallels the observation of 
reduced amplitude of 10 Hz evoked EPSPs in cultured rat hippocampal neurons and drosophila 
neuromuscular junctions, carrying mutations associated to familial FTD (i.e. P301L on tau) (Zhou et 
al., 2017). The authors hypothesized that this tauopathy-associated synaptic deficit is caused by the 
presynaptic interaction of the mutated tau N-terminus with neurotransmitter carrying vesicles. We 
observed an opposite result in Tau35 mice CA1-PCs, where 10 Hz facilitation was in fact more 
prominent in Tau35 mice in comparison to their WT littermates: the Tau35 fragment is a N-terminus 
truncated, C-terminus peptide, and the increased synaptic facilitation we observed might be related 
to its accumulation. However, a more controlled and direct experimental assessment of release 
probability would certainly be a worthwhile endeavour. This could be achieved, for example, with 
either emptage optical quantal methods or by studying the rate of block of post-synaptic EPSPs with 
a non-competitive NMDA-R antagonist such as MK-801. The time-course of the effect during a train, 
however, may point to an effect on presynaptic intracellular Ca
2+
 handling. A reduced ability to 
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dynamically buffer presynaptic Ca
2+
 would likely produce an outcome akin to that reported in Figure 
3. In this respect, it would be interesting, as a future development of the present work, to use 
imaging to measure the kinetics of pre-synaptic AP induced Ca
2+
 transients in CA3 pyramidal cells. 
 
If one embraces the well-established concept that a LTP-like process is pivotal to the establishment 
of hippocampal-dependent memory traces, one might ask how the normal LTP in Tau35 mice can be 
reconciled with the deficits these animals develop in a hippocampal-dependent learning task 
(Bondulich et al., 2016).  A potential solution to this dichotomy lies in consideration of the 
differences between the nature of a typical LTP experiment and how synaptic plasticity is generated 
in vivo. In the experimental situation, a stimulating electrode is used to simultaneously activate 
many presynaptic fibres both during the plasticity-inducing conditioning stimulus (typically a 100 Hz 
train or theta burst stimulus) and in the pre- and post-conditioning test periods. In vivo, however, 
plasticity-inducing patterns of neural firing are not produced by stimulating electrodes, but they 
instead relate to the intrinsic properties of the communicating neurons and how these shape various 
aspects of on-going input to the cell. Consequently, disease-associated changes to intrinsic 
properties could reduce or eliminate the generation of particular patterns of firing, including those 
required to induce LTP-like synaptic plasticity. For this and other reasons, we believe it is a useful 
endeavour to establish how intrinsic neuronal properties are modified by pathologies, as we and 
others have done in this and a number of other recent investigations (Booth et al., 2016a; Booth et 
al., 2016b; Brown et al., 2011; Kerrigan et al., 2014; Tamagnini et al., 2015a; Tamagnini et al., 2015b; 
Wykes et al., 2012).    
 
No differences in CA1-PC RMP were observed when comparing the genotypes. This agrees with our 
observations in another model of tauopathy  (Booth et al., 2016a; Booth et al., 2016b) and our 
investigations of CA1-PC in a variety of other models relating to human dementia (Brown et al., 
2011; Kerrigan et al., 2014; Tamagnini et al., 2015a; Tamagnini et al., 2015b). Although RMP was not 
altered, we did uncover changes to other intrinsic properties in experiments in which defined 
current pulses were injected into the cell via the recording electrode. These experiments were 
performed from two set pre-stimulus membrane potentials, -80 mV to match much of our previous 
work, and -74 mV, which was closer to the mean RMP in this study.  The capacitance, calculated 
from the ratio of input resistance and membrane time constant, was increased at both Vm tested. 
Indeed, as this measure should predominantly arise from the surface area of the cell and the 
insulating properties of the lipid bilayer it would be surprising if capacitances were found to be 
voltage-dependent. In line with this, the values determined at the two Vm within each genotype 
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were within <2.5% of each other.  The 20-23% increase in capacitance is probably due to the CA1-
PCs in Tau35 mice being larger. If the cells were a simple sphere this would be expect to equate to 
about a 6% increase in diameter or 12-13% increase in area, and although CA1-PC are geometrically 
much more complex a careful quantitative analysis of morphology would seem warranted. Another 
less likely possibility is that the dielectric properties of the membrane have changed, something 
which could arise from a substantial change to the biochemical make-up of the lipid bilayer.  
 
Membrane time constant, at around 20 ms, was very similar in Tau35 and WT mice, but Rin was 
lower in the former group (thus resulting in the calculated capacitance outcome described above). 
This lower Rin was only significantly different (by 15%) at -74 mV, whereas the 12% decrease 
observed at -80 mV was not significant. It is possible that the decrease in Rin represents a 
genomically-mediated compensatory mechanism engaged by the neurons to maintain their 
membrane time constant in the face of an increased capacitance. Commensurate with the expected 
Ohmic consequences of a lower Rin (i.e. a smaller voltage change for any given current), we observed 
a reduced spike output and lower spiking rates in CA1-PC at -74 mV (Figure 6). In fractional terms, 
these differences in spike output are greater with weaker current stimuli, which are more likely to 
have physiological pertinence. Thus, spike output is down by close to 50% when 50 pA is injected to 
cells at -74 mV, whereas the difference is only circa 20% with a 300 pA stimulus.  
 
The observation of a genotype-related difference between measurements made from -80 mV and -
74 mV points to the involvement of an ionic conductance that displays activation-gating within this 
voltage range. There are two prominent candidate conductances that fulfil this criteria in CA1-PCs, 
namely HCN channels and Kv7 channels. The presence of HCN channels is reflected in the higher Rin 
seen at -74 mV than -80 mV (something known classically as anomalous rectification), as well as the 
voltage “sag” observed when negative current is injected into the cells to hyperpolarize them. We 
recently reported changes to voltage sag in a different model of tauopathy (Booth et al., 2016a; 
Booth et al., 2016b), although the lack of genotype-related differences in this parameter in this 
model argues against, but perhaps does not entirely rule out, changes to HCN channels in Tau35 
mice. 
 
Our observations are consistent with the presence of more active Kv7 channels in the Tau35 mice. 
These voltage-gated K
+
 channels, which are responsible for the so-called M-current, are tonically 
active at rest in CA1-PCs and are turned on by further depolarization. Our observations of a lower Rin 
in Tau35 at -74 mV could reflect either a larger total number of channels in Tau35 mice or 
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alternatively a negative shift in the voltage-dependence of channel opening.  To date these have 
mainly been studied in the context of cancer epigenetics (Benoit et al., 2014). Notably, however, 
Tau35 mice have been shown to display increased GSK-3β activity (Bondulich et al., 2016) and this 
kinase is reported to modulate the gating properties of Kv7.2 channels via phosphorylation (Cooper 
et al., 2001; Singh et al., 1998; Wildburger and Laezza, 2012). In pyramidal neurons of the medial 
prefrontal cortex, inhibition of GSK-3β produces a hyperexcitability that mimics and occludes the 
effect of a Kv7 antagonist (Kapfhamer et al., 2010). Consequently, we hypothesize that in Tau35 
mice activation of Kv7 channels by GSK-3β-dependent phosphorylation can modify excitability in 
CA1-PCs.   
 
Our voltage-clamp recordings comparing K
+
 currents in somatic macropatches from WT and Tau35 
mice are certainly supportive of a negative shift in activation gating of a population of non-
inactivating voltage-gated K
+
 channels. However, we do not know what components of these 
currents, if any, result from activity of Kv7 channels. Some evidence indicates that Kv7 channels can 
be localized on the soma both with functional (Shah et al., 2011) and immunohistochemical 
measures (Cooper et al., 2001; Roche et al., 2002). However, these channels are thought to be more 
strongly localized on the axonal initial segment (AIS) and nodes of Ranvier. 
 
We also observed an increase in AP rate of rise in Tau35 mice. This was seen from both prestimulus 
membrane potentials examined.  We also observed a hyperpolarization of the AP threshold in Tau35 
animals, but only when the cells were at -80 mV prior to the stimulus. However, the voltage 
dependence of AP threshold change between genotypes should be considered with caution, as one 
value amongst the -74 mV, Tau35 population appears to be an outlier and its removal would bring 
the AP threshold to be significantly hyperpolarized in Tau35 mice at both tested potentials. These 
alterations to AP properties could also result from the activity of GSK-3β, which has been shown to 
increase docking of Ankyrin-G, which results in elongation of the AIS and an increased surface 
density of Nav1.6 channels. In fact, GSK-3β has been shown to promote the elongation of the AIS 
and the reduction of the AIS distance from the soma via increased Ankyrin-G docking, changing the 
AP waveform properties and cell excitability (Tapia et al., 2013). Figure 9 illustrates the mechanistic 
pathway potentially underlying our observations.  
Previous work showed a striking increase of CA1-PCs Ih-dependent resonance properties in rTg4510 
mice (Booth et al., 2016b), particularly increased Peak Fr and Q, but no changes in impedance: here, 
while no differences were observed in Peak Fr and Q, the overall impedance, measured as area 
under curve, was significantly smaller in Tau35, probably as a consequence of reduced input 
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resistance at depolarized potentials, possibly mediated by IM or other non-inactivating K
+
 currents: 
this could be interesting evidence suggesting how different forms of pathogenic tau can 
differentially affect neuronal resonance. 
The bi-directionality of excitability, depending on membrane potential, is an interesting observation. 
While studies carried out on genetic models of fronto-temporal dementia, such as rTg4510 mice, 
reveal an overall reduction of hippocampal network activity, presumably due to cell death (Booth et 
al., 2016b), other research works carried out on transgenic mice bearing a transgene associated to 
increased risk of sporadic fronto-temporal dementia, reveal hippocampal hyperexcitability  (Maeda 
et al., 2016; Siskova et al., 2014). Our observations reveal that single cell excitability in CA1-PCs may 
change with membrane potential in Tau35 mice, presumably decreasing during the raising phase of 
the wave and vice-versa: however, in order to causally relate these results to network alterations, an 
in vivo study involving electrophysiological recordings preferably in behaving animals is required. In 
particular, it has been shown that the administration of the histone deacetylase (HDAC) inhibitor 4-
phenyl butyrate in Tau35 mice results in the reduction of cognitive and motor impairment, GSK-3β 
activation and the associated hyperphosphorylation of tau protein; a key experiment, for exploring 
the mechanistic correlates of Tau35 altered electrophysiology described in this work, will be to test 
CA1-PC excitability and in vivo hippocampal network activity in 4-phenyl butyrate treated animals. 
In summary, we have identified a range of neurophysiological consequences in hippocampal neurons 
associated with the Tau35 genotype. Although experimentally induced LTP is intact, we observed an 
increase and decrease of excitability of Tau35 CA1-PCs at polarized and depolarized membrane 
potentials, respectively. We hypothesize that this change is mediated by the phosphorylation of Kv7 
and Nav1.6 channels, respectively, as increased GSK-3β activity is observed in Tau35 mice (Bondulich 
et al., 2016). A more detailed mechanistic characterization will be necessary to establish the 
causative role of GSK-3β in the electrophysiological alterations described in this work. 
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Table 1. Passive membrane properties measured in CA1-PCs of Tau35 and WT mice at two pre-
stimulus set potentials: Vm=-80 mV and Vm=-74 mV. Mean ± SEM and P values (unpaired Student’s 
t-test with Bonferroni correction -Pbc- for multiple comparisons) are shown for each.  
 
WT (n=28-32) Tau35 (n=40-46) 
  
Property Mean SEM Mean SEM Pbc 
2-Way MM 
ANOVA 
(Genotype) 
Ri (MΩ) at Vm=-80 mV 119.92 6.99 105.38 4.25 0.12 
F=6.06 P=0.016 
Ri (MΩ) at Vm=-74 mV 141.74 7.65 120.10 5.12 0.03 
sag (%) at Vm=-80 mV 16.01 1.24 13.94 0.85 0.32 
F=1.99 P=0.163 
sag (%) at Vm=-74 mV 12.50 1.43 10.43 0.97 0.43 
τ (ms) at Vm=-80 mV 18.95 0.84 19.98 0.66 0.67 
F=0.40 P=0.529 
τ (ms) at Vm=-74 mV 22.06 1.14 22.50 0.83 1 
Cap (pF) at Vm=-80 mV 134.22 9.30 163.71 7.46 0.03 
F=10.21 P=0.002 
Cap (pF) at Vm=-74 mV 132.52 8.68 167.08 7.05 0.005 
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Table 2. Sub-threshold resonance membrane properties measured in CA1-PCs of Tau35 and WT 
mice at two pre-stimulus set potentials: Vm=-80 mV and Vm=-74 mV. Mean ± SEM and P values 
(unpaired Student’s t-test) are shown for each.  
 
WT n=30 Tau35 n=48 
 
Property Mean SEM Mean SEM P 
Peak Fr (Hz) 2.8 0.2 2.5 0.2 0.3 
Peak Z (MΩ) 169.8 11.4 148.7 12.0 0.2 
Q 1.07 0.01 1.05 0.01 0.4 
AUC (MΩ*Hz) 1725 103 2191 153 0.01 
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Table 3. AP waveform properties measured in CA1-PCs of Tau35 and WT mice at two pre-stimulus 
set potentials: Vm=-80 mV and Vm=-74 mV. Mean ± SEM and P values (Two-way ANOVA and 
unpaired Student’s t-test with Bonferroni correction -Pbc- for multiple comparisons) are shown for 
each.  
 
WT (n=26-29) Tau35 (n=30-41) 
  
Property Mean SEM Mean SEM Pbc 2-Way MM ANOVA 
Width (ms) at Vm=-80 mV 0.80 0.04 0.82 0.02 1 
F=0.698 P=0.407 
Width (ms) at Vm=-74 mV  0.80 0.04 0.84 0.02 0.6 
Peak (mV) at Vm=-80 mV 21.59 2.10 23.24 1.53 1 
F=0.690  P=0.410 
Peak (mV) at Vm=-74 mV 21.60 1.71 24.23 1.45 0.5 
Thr (mV) at Vm=-80 mV -64.53 0.71 -67.38 0.61 0.006 
F=4.923 P=0.031 
Thr (mV) at Vm=-74 mV -63.46 0.62 -64.94 0.56 0.2 
RoR (V/s) at Vm=-80 mV 245.02 21.01 311.59 19.35 0.048 
F=5.661 P=0.021 
RoR (V/s) at Vm=-74 mV 240.69 19.63 306.81 17.54 0.03 
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Figure Legends 
 
Figure 1. Schematic representation of the Tau35 fragment in comparison to full-length human tau. 
Tau is alternatively spliced and the largest CNS isoform of human tau comprises two N-terminal 
inserts, followed by a proline-rich domain and four microtubule binding repeats (2N4R tau, 441 
amino acids). The Tau35 sequence includes residues 187-441 of 2N4R human tau fused at the C-
terminus to a haemagglutinin tag (HA). 
 
Figure 2. Long-term potentiation in CA1 of hippocampal slices prepared from Tau35 mice is 
normal. 
(A) Average trace of an evoked fEPSP during the baseline (black) and final 20 minutes (grey) of a 
single SC LTP experiment. (B) Sample traces of the theta burst induction protocol used to induce LTP. 
(C) Extracellular recordings of evoked  fEPSPs in hippocampal CA1 do not show differences in LTP 
induction between Tau35 and age-matched WT littermate controls. We tested 2 different pathways 
to CA1: the Shaffer Collateral (SC) pathway (top panel) and the Temporo-Ammonic (TA) pathway 
(bottom panel). 
 
Figure 3. Increased facilitation of the excitatory synaptic transmission in the SC-CA1 pathway at 
theta-range (10 Hz) stimulation frequencies in Tau35 CA1-PCs. 
A. Example traces showing 6 evoked EPSPs from 2 patch-clamp, current-clamp recordings in CA1-PCs 
from WT (top-black) and Tau35 (bottom-red) mice; in this case, facilitation was obtained by 
delivering the stimuli on the SC pathway at 10 Hz (theta-range). B. Each cell received a complete set 
of stimulus frequencies: 1 Hz, 3 Hz, 10 Hz (theta range) and 30 Hz (low-gamma range). While no 
differences between genotypes were observed at 1 Hz, 3 Hz and 30 Hz (at this latter frequency both 
genotypes showed sustained facilitation), at 10 Hz Tau35 C 1-PCs showed sustained facilitation 
along all of 6 pulses, whereas WT controls came back to baseline after the second pulse. 
 
Figure 4. Tau35 CA1-PCs had similar RMPs to WT neurons. 
Cumulative probability curve showing cell-to-cell RMP probability in Tau35 and age-matched WT 
littermate controls. No differences were observed between genotypes (see Table 1 for mean ± SEM 
and P values). 
 
Figure 5. Tau35 CA1-PCs have altered passive membrane properties. 
A-B. Passive membrane properties of CA1-PCs were tested in Tau35 and age-matched WT littermate 
controls with current-clamp whole-cell Vm recordings upon the injection of a -100 pA, 500 ms current 
step at two different fixed pre-stimulus potentials, -80 mV (A) and -74 mV (B), obtained with a 
constant current injection. Top panels show the averaged ± SEM Vm responses while bottom panels 
show scatter plots of cell-to-cell analysis of the tested passive properties: Rin, τ, capacitance and sag. 
The boxes on the right of each scatter distribution (in this and following figures) represent the mean 
(small square) median and SEM boundaries. While capacitance was higher at both tested voltages, 
Rin was significantly reduced only when tested at Vm = -74 mV (unpaired Student’s t-test with 
Bonferroni correction: Pbc). C. Impedance was reduced in the resonance profile of Tau35 mice (right 
panel), obtained with the injection of a sub-threshold sinusoidal oscillating current with a frequency 
linearly increasing between 0.5 Hz and 20 Hz (left panel, bottom trace); the top traces in the left 
panel are representative examples, for each genotype, of the Vm oscillating in response to the 
sinusoidal current injection. 
 
Figure 6. Tau35 CA1-PCs are hypoexcitable at depolarized but not hyperpolarized potentials.  
The average (top panels) and instantaneous (bottom panels; only +300 pA step is shown) firing 
frequencies of CA1-PCs were tested in Tau35 and age-matched WT littermate controls with current-
clamp whole-cell Vm recordings upon the injection of 500 ms, +50 pA to +300 pA. While no 
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differences were observed between genotypes at Vm=-80 mV (A), a significant reduction of both 
average and instantaneous firing frequencies was observed in Tau35 mice at Vm =-74 mV; such 
reduction in firing rate at more depolarized potentials is probably a reflection  of the respective 
reduction in Rin, as described in Figure 5A-B.  
 
Figure 7. Tau35 CA1-PCs have altered action potential kinetics. 
A-B. Top panels show the averaged ± SEM Vm responses corresponding to the first AP fired upon the 
injection of a 500 ms, +300 pA recorded from CA1-PCs in Tau35 and age-matched WT littermate 
controls from a pre-stimulus potential of -80 mV (A) or -74 mV (B); middle panels show the 
corresponding phase-plots of the first Vm  derivative in time vs Vm: these show a visible difference in 
the rate of rise around a Vm =-20 mV and hyperpolarization of the AP threshold, more clearly visible 
in the corresponding expanded phase-plot in the bottom panel. C-F. Cell-to-cell analysis of the AP 
waveform properties, revealed a significant increase of AP rate of rise at both -80 mv (E) and -74 mV 
(F) pre-stimulus Vm, while the AP threshold resulted significantly hyperpolarized only at Vm=-80 mV 
(C) but not at Vm=-74 mV (D); this could be due to a voltage-dependent  dampening effect, the same 
one that provoked voltage-dependent decrease in Rin and firing rate. 
 
Figure 8. Activation of somatic non-inactivating K
+
 currents occurs at more negative potentials in 
Tau35 CA1-PCs 
A. Photograph of an outside-out nucleated somatic macropatch, excised from a CA1-PC of a Tau35 
mouse in order to measure the biophysical properties of voltage-gated non-inactivating outward 
currents (IK). B. Example current traces evoked by 30 ms, +40/+60/+80/+100/+120 mV voltage steps, 
from a pre-stimulus voltage clamped at -90 mV. After fast inactivating inward and outward currents, 
the IK persisted until the end of the voltage step stimulation. C. Sigmoidal increase of IK specific 
conductance from a baseline Vm = -90 mV upon 10 mV voltage steps. Analysis of IK  biophysical 
properties was performed by calculating the maximal conductance (Gmax) and voltage-sensitivity 
(V1/2) with cell-to-cell Boltzman fits. No effect of the genotype was observed on IK’s Gmax, however a 
significant hyperpolarization of the V1/2 was observed in Tau35 CA1-PCs. This can be more clearly 
appreciated in D, which shows the IV curve normalized vs the measured G maximal value for each 
cell. C and D show mean ± SEM values while the dashed lines represent the sigmoidal Boltzman fit 
for the mean values.  
 
Figure 9. Schematic representation of the cascade of events potentially connecting Tau35 
accumulation to altered intrinsic excitability of hippocampal CA1-PCs. 
Tau35 accumulation results in activation of GSK-3β (Bondulich et al., 2016), which has been reported 
to decrease the gating potential of Kv7.2 channels and to increase Nav1.6 docking on the AIS via the 
AIS-associated protein AnkG.  These events might be responsible for the reduced intrinsic excitability 
observed in Tau35 mice. Hyperpolarization of Kv7.2 channels V1/2 could reduce input resistance and 
AP firing rate at depolarized potentials, whereas increased docking of Nav1.6 channels to the axonal 
initial segment could reduce the AP threshold and increase the AP maximal rate of rise. The causal 
relationship between these electrophysiological alterations and the cognitive decline observed in 
the Tau35 model of sporadic tauopathy remains to be clarified. 
Acronyms: AIS = xonal initial segment; AnkG = Ankyrin G; AP = Action potential; GSK-3β = Glycogen 
Synthase Kinase 3β; Kv 7.2 = voltage-gated K
+
 channels 7.2; Nav 1.6 = voltage-gated Na
+
 channels 1.6; 
Rin= input resistance; Thr = Threshold; ROR = max Rate of Rise; V1/2 = half-activation potential; Vm = 
membrane potential. 
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Highlights 
•         Tau35 mice CA1 hippocampal function was tested with slice electrophysiology 
•         10Hz train stimuli reveal impaired short-term plasticity in Tau35 SC-CA1 synapses 
•         Tau35 CA1 pyramidal neurons show hypoexcitability at depolarized potentials 
•         Modified properties of voltage-gated K
+
 currents might underlie altered excitability 
•         Action potential waveforms rise faster and have lower thresholds 
 
